• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢组学指出卡非佐米对芳香族氨基酸生物合成和降解的影响。

Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation.

机构信息

Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece.

Laboratory of Pharmacology, Department of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece.

出版信息

Int J Mol Sci. 2023 Sep 12;24(18):13966. doi: 10.3390/ijms241813966.

DOI:10.3390/ijms241813966
PMID:37762269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10530946/
Abstract

(1) Carfilzomib (Cfz) is an antineoplastic agent indicated for the treatment of multiple myeloma. However, its beneficial action is attenuated by the occurrence of cardiotoxicity and nephrotoxicity as the most common adverse effects. Presently, there is well-established knowledge on the pathomechanisms related to these side effects; however, the research on the metabolic alterations provoked by the drug is limited. (2) An in vivo simulation of Cfz-induced toxicity was developed in (i) Cfz-treated and (ii) control mice. An RP-HRMS-based protocol and an advanced statistical treatment were used to investigate the impact of Cfz on the non-polar metabolome. (3) The differential analysis classified the Cfz-treated and control mice and resulted in a significant number of identified biomarkers with AUC > 0.9. The drug impaired the biosynthesis and degradation of aromatic amino acids (AAA) and led to alterations of uremic toxins in the renal and urine levels. Furthermore, the renal degradation of tryptophan was affected, inducing its degradation via the kynurenine pathway. (4) The renal levels of metabolites showed impaired excretion and degradation of AAAs. Cfz was, finally, correlated with the biosynthesis of renal dopamine, explaining the biochemical causes of water and ion retention and the increase in systolic pressure.

摘要

(1) 卡非佐米(Cfz)是一种抗肿瘤药物,适用于多发性骨髓瘤的治疗。然而,其作为最常见的不良反应的心脏毒性和肾毒性会削弱其有益作用。目前,人们对这些副作用的发病机制有了明确的认识;然而,关于药物引起的代谢改变的研究是有限的。(2) 在(i)Cfz 处理和(ii)对照小鼠中建立了 Cfz 诱导毒性的体内模拟。采用基于 RP-HRMS 的方案和先进的统计处理来研究 Cfz 对非极性代谢组的影响。(3) 差异分析对 Cfz 处理组和对照组的小鼠进行分类,得到了大量 AUC>0.9 的鉴定生物标志物。该药物损害了芳香族氨基酸(AAA)的生物合成和降解,并导致肾脏和尿液水平的尿毒症毒素发生变化。此外,色氨酸的肾脏降解受到影响,通过犬尿氨酸途径诱导其降解。(4) 肾脏水平的代谢物显示出 AAA 的排泄和降解受损。Cfz 与肾多巴胺的生物合成有关,解释了水和离子潴留以及收缩压升高的生化原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/fcc094b8eb7f/ijms-24-13966-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/8af75dd1ba89/ijms-24-13966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/2c4817cfe341/ijms-24-13966-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/94d8df42b48f/ijms-24-13966-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/ecdbf951b6ce/ijms-24-13966-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/62a33743789b/ijms-24-13966-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/72832b41a09d/ijms-24-13966-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/05a95138cfe8/ijms-24-13966-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/fcc094b8eb7f/ijms-24-13966-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/8af75dd1ba89/ijms-24-13966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/2c4817cfe341/ijms-24-13966-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/94d8df42b48f/ijms-24-13966-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/ecdbf951b6ce/ijms-24-13966-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/62a33743789b/ijms-24-13966-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/72832b41a09d/ijms-24-13966-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/05a95138cfe8/ijms-24-13966-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd6/10530946/fcc094b8eb7f/ijms-24-13966-g008.jpg

相似文献

1
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation.代谢组学指出卡非佐米对芳香族氨基酸生物合成和降解的影响。
Int J Mol Sci. 2023 Sep 12;24(18):13966. doi: 10.3390/ijms241813966.
2
An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity.基于非靶向代谢组学的卡非佐米肾毒性研究。
Molecules. 2022 Nov 16;27(22):7929. doi: 10.3390/molecules27227929.
3
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib.研究不可逆蛋白酶体抑制剂卡非佐米的血管毒性结局。
Int J Mol Sci. 2020 Jul 22;21(15):5185. doi: 10.3390/ijms21155185.
4
Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity.在卡非佐米诱导的心脏毒性中,心脏代谢综合征和早期心力衰竭的意义和潜在毒性。
Br J Pharmacol. 2024 Aug;181(16):2964-2990. doi: 10.1111/bph.16391. Epub 2024 Apr 28.
5
Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway.芦丁通过 NOS 介导的 NF-κB 信号通路抑制卡非佐米诱导的氧化应激和炎症。
Inflammopharmacology. 2019 Aug;27(4):817-827. doi: 10.1007/s10787-018-0550-5. Epub 2019 Jan 1.
6
Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.卡非佐米相较于硼替佐米对果蝇模型的退行性影响更小:与临床不良事件相关联。
Sci Rep. 2017 Dec 19;7(1):17802. doi: 10.1038/s41598-017-17596-4.
7
Polymer micelle formulations of proteasome inhibitor carfilzomib for improved metabolic stability and anticancer efficacy in human multiple myeloma and lung cancer cell lines.蛋白酶体抑制剂卡非佐米的聚合物胶束制剂,用于提高在人多发性骨髓瘤和肺癌细胞系中的代谢稳定性及抗癌疗效。
J Pharmacol Exp Ther. 2015 Nov;355(2):168-73. doi: 10.1124/jpet.115.226993. Epub 2015 Aug 26.
8
Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.尿液代谢组学揭示转基因CRND8小鼠阿尔茨海默病芳香族氨基酸代谢的改变
Curr Alzheimer Res. 2016;13(7):764-76. doi: 10.2174/1567205013666160129095340.
9
Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin.卡非佐米诱导小鼠心脏毒性的分子机制和二甲双胍的新兴心脏保护作用。
Blood. 2019 Feb 14;133(7):710-723. doi: 10.1182/blood-2018-06-858415. Epub 2018 Nov 27.
10
Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats.右丙亚胺通过抑制大鼠肥厚基因表达和氧化应激减轻卡非佐米诱导的心脏毒性。
Toxicol Mech Methods. 2016;26(3):189-95. doi: 10.3109/15376516.2016.1143071. Epub 2016 Feb 21.

本文引用的文献

1
An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity.基于非靶向代谢组学的卡非佐米肾毒性研究。
Molecules. 2022 Nov 16;27(22):7929. doi: 10.3390/molecules27227929.
2
Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of Eplerenone.盐皮质激素受体途径是卡非佐米诱导肾毒性的关键介质:依普利酮的预防作用。
Hemasphere. 2022 Oct 18;6(11):e791. doi: 10.1097/HS9.0000000000000791. eCollection 2022 Nov.
3
Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation.
微生物衍生色氨酸代谢产物、肾脏疾病和肠道炎症。
Toxins (Basel). 2022 Sep 18;14(9):645. doi: 10.3390/toxins14090645.
4
Short-Chain Fatty Acids in the Metabolism of Heart Failure - Rethinking the Fat Stigma.心力衰竭代谢中的短链脂肪酸——重新审视脂肪的污名
Front Cardiovasc Med. 2022 Jul 11;9:915102. doi: 10.3389/fcvm.2022.915102. eCollection 2022.
5
The Footprint of Kynurenine Pathway in Cardiovascular Diseases.犬尿氨酸途径在心血管疾病中的印记
Int J Tryptophan Res. 2022 Jun 28;15:11786469221096643. doi: 10.1177/11786469221096643. eCollection 2022.
6
Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities.肾脏疾病中的脂肪酸β-氧化:病理生理机制与治疗机会的展望
Front Pharmacol. 2022 Apr 20;13:805281. doi: 10.3389/fphar.2022.805281. eCollection 2022.
7
Association of Plasma Branched-Chain and Aromatic Amino Acids with Reduction in Kidney Function Evaluated in Apparently Healthy Adults.在看似健康的成年人中评估血浆支链氨基酸和芳香族氨基酸与肾功能下降的关联。
J Clin Med. 2021 Nov 10;10(22):5234. doi: 10.3390/jcm10225234.
8
Kynurenine pathway in kidney diseases.色氨酸代谢途径与肾脏疾病。
Pharmacol Rep. 2022 Feb;74(1):27-39. doi: 10.1007/s43440-021-00329-w. Epub 2021 Oct 6.
9
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.3-羟基-L-犬尿氨酸是一种免疫调节生物胺。
Nat Commun. 2021 Jul 21;12(1):4447. doi: 10.1038/s41467-021-24785-3.
10
Tryptophan and indole metabolism in immune regulation.色氨酸与吲哚代谢在免疫调节中的作用
Curr Opin Immunol. 2021 Jun;70:7-14. doi: 10.1016/j.coi.2020.12.001. Epub 2021 Jan 5.